15-89323966-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_002693.3(POLG):c.2071-65G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0033 in 1,536,812 control chromosomes in the GnomAD database, including 50 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0032 ( 9 hom., cov: 33)
Exomes 𝑓: 0.0033 ( 41 hom. )
Consequence
POLG
NM_002693.3 intron
NM_002693.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.467
Publications
6 publications found
Genes affected
POLG (HGNC:9179): (DNA polymerase gamma, catalytic subunit) Mitochondrial DNA polymerase is heterotrimeric, consisting of a homodimer of accessory subunits plus a catalytic subunit. The protein encoded by this gene is the catalytic subunit of mitochondrial DNA polymerase. The encoded protein contains a polyglutamine tract near its N-terminus that may be polymorphic. Defects in this gene are a cause of progressive external ophthalmoplegia with mitochondrial DNA deletions 1 (PEOA1), sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO), Alpers-Huttenlocher syndrome (AHS), and mitochondrial neurogastrointestinal encephalopathy syndrome (MNGIE). Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
POLG Gene-Disease associations (from GenCC):
- progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- mitochondrial DNA depletion syndrome 4aInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Orphanet, G2P
- sensory ataxic neuropathy, dysarthria, and ophthalmoparesisInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P
- autosomal dominant progressive external ophthalmoplegiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive progressive external ophthalmoplegiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- mitochondrial neurogastrointestinal encephalomyopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- recessive mitochondrial ataxia syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- spinocerebellar ataxia with epilepsyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Leigh syndromeInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00324 (494/152346) while in subpopulation EAS AF = 0.0494 (256/5184). AF 95% confidence interval is 0.0444. There are 9 homozygotes in GnomAd4. There are 245 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 9 AR,AD gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00324 AC: 493AN: 152228Hom.: 9 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
493
AN:
152228
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00331 AC: 4576AN: 1384466Hom.: 41 Cov.: 23 AF XY: 0.00328 AC XY: 2270AN XY: 692798 show subpopulations
GnomAD4 exome
AF:
AC:
4576
AN:
1384466
Hom.:
Cov.:
23
AF XY:
AC XY:
2270
AN XY:
692798
show subpopulations
African (AFR)
AF:
AC:
29
AN:
31968
American (AMR)
AF:
AC:
17
AN:
44530
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25610
East Asian (EAS)
AF:
AC:
1832
AN:
39290
South Asian (SAS)
AF:
AC:
352
AN:
84664
European-Finnish (FIN)
AF:
AC:
181
AN:
53234
Middle Eastern (MID)
AF:
AC:
3
AN:
5624
European-Non Finnish (NFE)
AF:
AC:
1879
AN:
1041764
Other (OTH)
AF:
AC:
283
AN:
57782
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
271
542
813
1084
1355
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
98
196
294
392
490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00324 AC: 494AN: 152346Hom.: 9 Cov.: 33 AF XY: 0.00329 AC XY: 245AN XY: 74498 show subpopulations
GnomAD4 genome
AF:
AC:
494
AN:
152346
Hom.:
Cov.:
33
AF XY:
AC XY:
245
AN XY:
74498
show subpopulations
African (AFR)
AF:
AC:
35
AN:
41578
American (AMR)
AF:
AC:
9
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
256
AN:
5184
South Asian (SAS)
AF:
AC:
20
AN:
4830
European-Finnish (FIN)
AF:
AC:
41
AN:
10624
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
124
AN:
68036
Other (OTH)
AF:
AC:
9
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
25
50
75
100
125
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
105
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.